CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- 4 Planned sale Henn Matthew R. sold 891 shares at $0.94 ($838)
- 4 Planned sale Ege David S. sold 1,090 shares at $0.94 ($1,025)
- 4 Planned sale Chief Legal Officer and EVP sold 843 shares at $0.94 ($792)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Legal Officer and EVP sold 3,939 shares at $1.08 ($4,254)
- 4 Planned sale CEO and President sold 11,549 shares at $1.08 ($12,473)
- 4 Planned sale Henn Matthew R. sold 4,170 shares at $1.08 ($4,504)
- 4 Planned sale Young Teresa L. sold 3,374 shares at $1.08 ($3,644)
- 4 Planned sale von Moltke Lisa sold 4,400 shares at $1.08 ($4,752)
- 4 Planned sale Ege David S. sold 5,010 shares at $1.08 ($5,411)
- 4 Planned sale Chief Financial Officer sold 3,939 shares at $1.08 ($4,254)
- 4 Planned sale Cloghessy Paula sold 2,904 shares at $1.35 ($3,920)
Page 6 of 19 · 380 filings